HSP90AB1 and pulmonary arterial hypertension: Studies have found that HSP90 inhibitors can improve pulmonary arteriole remodeling by inhibiting the extensive proliferation of PASMCs; thus, inhibiting HSP90 may be an effective treatment for PAH [74].